Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT03575871

Public ClinicalTrials.gov record NCT03575871. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 6:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-04965842 MONOTHERAPY IN SUBJECTS AGED 12 YEARS AND OLDER, WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Study identification

NCT ID
NCT03575871
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
391 participants

Conditions and interventions

Interventions

  • PF-04965842 100 mg Drug
  • PF-04965842 200 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 28, 2018
Primary completion
Aug 12, 2019
Completion
Aug 12, 2019
Last update posted
Apr 20, 2020

2018 – 2019

United States locations

U.S. sites
28
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
Emmaus Research Center, Inc. Anaheim California 92804
Advanced Research Center, Inc. - Los Alamitos Site Los Alamitos California 90720
Peninsula Research Associates, Inc. Rolling Hills Estates California 90274
Clinical Science Institute Santa Monica California 90404
Asthma and Allergy Associates, PC Colorado Springs Colorado 80907
Colorado Springs Dermatology Clinic, PC Colorado Springs Colorado 80910
Olympian Clinical Research Clearwater Florida 33756
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256
Precision Imaging Jacksonville Florida 32256
Solutions Through Advanced Research, Inc. Jacksonville Florida 32256
Clinical Neuroscience Solutions, Inc Orlando Florida 32801
ForCare Clinical Research Tampa Florida 33613
Imaging Center of Idaho Caldwell Idaho 83605
ASR, LLC Nampa Idaho 83687
Meridian Clinical Research Baton Rouge Louisiana 70808
Massachusetts General Hospital Boston Massachusetts 02114
MediSearch Clinical Trials Saint Joseph Missouri 64506
Sadick Research Group New York New York 10075
PMG Research of Wilmington, LLC Wilmington North Carolina 28411
The Ohio State University Wexner Medical Center Columbus Ohio 43210
The Ohio State University Dermatology East Gahanna Ohio 43230
Tanenbaum Dermatology Center Memphis Tennessee 38117
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119
Austin Institute for Clinical Research, Inc. - Central Austin Texas 78705
Center for Clinical Studies, LTD. LLP Houston Texas 77004
West Houston Dermatology, PA Houston Texas 77082
Summit Clinical Research, LLC Franklin Virginia 23851
Virginia Dermatology and Skin Cancer Center Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03575871, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2020 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03575871 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →